Categories: News

West Island Makes First Delivery to SQDC

Dorval, Quebec–(Newsfile Corp. – June 28, 2022) – West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTC Pink: WIBFF) (“West Island” or the “Company”) is pleased to announce that further to our news release of January 17, 2022, West Island’s subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A West Island Culture has forwarded its first shipments cannabis products to the Province of Quebec.

West Island has been approved for a general listing of four SKUs in by the Société Québécoise Du Cannabis (the “SQDC”):

  • OUESTTM: Our premium brand will be represented by ‘Grandpa’s Stash’ and ‘Jelly Cake’ flower offerings. Both products stand out for the high content of THC and terpenes. We are convinced that these products will be appreciated by cannabis connoisseurs who are looking for products without compromise.
  • CITOYENTM: Our “People’s Flower” brand will be represented by the “King Louis” and “Clementine Punch” flower offerings. Both of these products come with unique terpene profiles. We are also confident that these two products will validate our brand’s mission to bring high quality craft cannabis to all consumers.

West Island CEO, Boris Ziger states, “West Island is thrilled to finally be in its home province of Quebec. Since the success of CITIZEN™ and our premium brands OUEST™ of craft cannabis in other parts of Canada, we can’t wait to bring them home. We expect Quebec to be one of our biggest markets in Canada, which makes it a very important step in the development of the company.”

About West Island

West Island is a multi-faceted, innovative company in the Quebec cannabis space. Its subsidiary, RoyalMax Biotechnology Canada Inc. is a Dorval, Quebec based Health Canada Licence Holder with standard cultivation licence, standard processing, medical sales and sales licences. The Company continues to work with Yunify Natural Technologies, a Quebec based health and personal care research and innovation company to develop proprietary products for West Island including topicals and ionic mists. Through its acquisition of Trichome Treats, an award-winning chocolatier, the Company intends on introducing edibles into the West Island product mix.

For more information on West Island Brands please visit the website at: westislandbrands.com.

On behalf of the Board of Directors
WEST ISLAND BRANDS INC.

Boris Ziger

Boris Ziger, CEO & Chairman

The Company’s public filings are available for review at www.sedar.com and www.thecse.com.

For further information, please contact:
Boris Ziger, CEO at:
Telephone: 416-304-9935
E-mail:
info@westislandbrands.com
Website:
www.westislandbrands.com

Boris Ziger, PDG de :
Téléphone : 416-304-9935
Courriel : info@westislandbrands.com
Site Web : www.westislandbrands.com

Disclaimer for Forward-Looking Information

Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/129208

Staff

Recent Posts

Unique Treatment for BPH, Chronic Prostatitis, Back Pain and Kidney Stones Was Unveiled at Arab Health 2024 by Ariana Adjani

* Efficacy, safety, and cost-effectiveness of Thermobalancing therapy and Dr Allen's Devices were showcased at…

19 hours ago

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

2 days ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

2 days ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

2 days ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

2 days ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

2 days ago